Cancer cells increase the cellular concentrations of hemin and protoporphyrin by both the activate synthesis of the compounds as a result of the activated RAS/MEK pathway [221], and the upregulation of two ABC transporters: ABCG2 and ABCB6 [222,223]. The gene discussed is MAP2K7; the disease is cancer.